Table 2.
SNP rs3863377(G→ A) | ||||||||
|
WT [GG] |
Het [GA] |
Hom [AA] (%) |
P |
P’ |
OR |
CI |
χ2 |
non-IBD |
506 (94.4) |
28 (5.2) |
2 (0.4) |
|
|
|
|
0.14 |
IBD |
438 (97.8) |
10 (2.2) |
0 |
0.009** † |
0.022* |
0.39 |
0.19-0.80 |
0.01 |
CD |
271 (97.8) |
6 (2.2) |
0 |
0.030* † |
0.031* |
0.37 |
0.15-0.191 |
0.01 |
UC |
167 (97.7) |
4 (2.3) |
0 |
0.100 † |
0.066 |
0.40 |
0.14-1.16 |
0.01 |
SNP rs56163822(−1G → T) | ||||||||
|
WT [GG] |
Het [GT] |
Horn [TT] (%) |
P |
P’ |
OR |
CI |
χ2 |
non-IBD |
560 (96.6) |
20 (3.4) |
0 |
|
|
|
|
0.04 |
IBD |
505 (93.9) |
33 (6.1) |
1 (0.09) |
0.035* |
0.451 |
1.83 |
1.04-3.23 |
0.00 |
CD |
319 (94.4) |
19 (5.6) |
1 (0.09) |
0.115 |
0.846 |
1.67 |
0.88-3. 17 |
0.00 |
UC |
186 (93.0) |
14 (7.0) |
0 |
0.034* |
0.154 |
2.11 |
1.04-4.26 |
0.13 |
SNP rs7138843(A → T) | ||||||||
|
WT [AA] |
Het [AT] |
Horn [TT] (%) |
P |
P’ |
OR |
CI |
χ2 |
non-IBD |
495 (96.7) |
17 (3.3) |
0 |
|
|
|
|
0.03 |
IBD |
417 (95.2) |
21 (4.8) |
0 |
0.248 |
0.772 |
147 |
0.76-2.82 |
0.06 |
CD |
261 (96.0) |
11 (4.0) |
0 |
0.369 † |
0.612 |
1.23 |
0.57-2.66 |
0.04 |
UC |
156 (94.0) |
10 (6.0) |
0 |
0.097 † |
0.981 |
1.87 |
0.84-4.16 |
0.10 |
SNP rs10860603(G → A) | ||||||||
|
WT [GG] |
Het [GA] |
Horn [AA] (%) |
P |
P’ |
OR |
CI |
χ2 |
non-IBD |
424 (72.8) |
143 (24.6) |
15 (2.6) |
|
|
|
|
049 |
IBD |
407 (75.8) |
121 (22.5) |
9 (1.7) |
0.261 |
0.384 |
0.86 |
0.66-1.12 |
0.00 |
CD |
254 (75.4) |
76 (22.5) |
7 (2.1) |
0.403 |
0.611 |
0.88 |
0.65-1.19 |
0.22 |
tiC |
153 (76.5) |
45 (22.5) |
2 (1.0) |
0.312 |
0.521 |
0.82 |
0.57-1.19 |
0.43 |
SNP rs35724(G→ C) | ||||||||
|
WT [GG] |
Het [GC] |
Horn [CC] (%) |
P |
P’ |
OR |
CI |
χ2 |
non-IBD |
217 (37.3) |
264 (454) |
101 (17.3) |
|
|
|
|
1.78 |
IBD |
177 (32.9) |
251 (46.7 |
110 (20.4) |
0.125 |
0.209 |
1.213 |
0.95-1.55 |
1.47 |
CD |
111 (32.8) |
155 (45.9) |
72 (21.3) |
0.175 |
0.279 |
1.216 |
0.92-1.61 |
1.68 |
UC | 66 (33.0) | 96 (48.0) | 38 (19.0) | 0.277 | 0.233 | 1.207 | 0.86-1.69 | 0.09 |